This leads to low fatty acid beta-oxidation, decreased insulin signaling and low HDL-cholesterol levels, thus raising the risk for MetS [18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35]. The gene discussed is INS; the disease is metabolic syndrome.